Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $132.5100 (9.48%) ($125.9500 - $132.5100) on Tue. Aug. 31, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.92% (three month average) | RSI | 71 | Latest Price | $132.5100(9.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 2.9% a day on average for past five trading days. | Weekly Trend | LGND advances 5.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) IWM(56%) IWC(54%) IWN(51%) | Factors Impacting LGND price | LGND will decline at least -1.46% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) IGOV(-6%) UNG(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.46% (StdDev 2.92%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $118.57(11.76%) | 10 Day Moving Average | $114.14(16.09%) | 20 Day Moving Average | $111.47(18.88%) | To recent high | -3.6% | To recent low | 29.4% | Market Cap | $2.13b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |